Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany

Dividend Information

The current dividend constitutes the minimum level, assuming a stable economic environment. While Merck KGaA, Darmstadt, Germany, aims to continuously develop dividends in line with business performance and earnings progression, dividend growth can deviate, e.g. in times of restructuring or because of significant global economic developments. Merck KGaA, Darmstadt, Germany, also aims at a target corridor of 20-25% of EPS pre.
Dividend Development

Dividend yield: 1.2% (based on closing price of December 30th, 2015)
1 Adjusted to the new number of shares after the share split (June 30, 2014) 
*Forward Looking Statement: Subject to operational performance,economic environment and approval by the AGM.

DISCLAIMER

Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK. Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in biopharma, “MilliporeSigma” in life science and “EMD Performance Materials” in materials business. The other company, Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada. Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.   To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone.  Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.
 
RSS FEEDS
Open the following links in a RSS Reader of your choice